Home | Triveni Bio

Multicolored pattern and antibody representing Triveni’s genetics-informed precision medicine approach to develop functional antibodies.

About us

We are pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of immunological and inflammatory (I&I) disorders.

Through our proprietary platform, we hunt for and derisk novel therapeutic targets with strong genetic rationale across diseases, predict and stratify patient subpopulations, and provide insights into disease mechanisms.

Leadership Team

Our experienced team is backed by an industry-leading board of directors, strategic advisors, and key opinion leaders.

Leadership Team
Board of Directors
Key Advisors
Investors

Vishal Patel, PhD

Chief Executive Officer

View Bio

Jennifer Dovey, PhD

Chief Scientific Officer

View Bio

Nicholas Scarchilli

Chief Operating Officer

View Bio

Bhaskar Srivastava, MD, PhD

Chief Medical Officer

View Bio

Will Chen, PhD

Head of Platform, Senior Advisor

View Bio

David Erbe, PhD

Head, Early Development

View Bio

Eva Asp, PhD

Head, Biology

View Bio

Brantley Herrin, PhD

Head, Biologics

View Bio

Careers and culture

We are committed to recruiting the best and brightest minds to our growing team to advance a novel and innovative pipeline of I&I therapies.

Together, we have the potential to address some of the most challenging diseases for which limited treatment options exist – through enabling exciting biological discoveries.

Interested in working with us? Browse job opportunities